Invention Grant
US09382244B2 7-azaindole-2,7-naphthyridine derivative for the treatment of tumours
有权
7-氮杂吲哚-2,7-萘啶衍生物用于治疗肿瘤
- Patent Title: 7-azaindole-2,7-naphthyridine derivative for the treatment of tumours
- Patent Title (中): 7-氮杂吲哚-2,7-萘啶衍生物用于治疗肿瘤
-
Application No.: US14432767Application Date: 2013-09-09
-
Publication No.: US09382244B2Publication Date: 2016-07-05
- Inventor: Alfred Jonczyk , Frank T. Zenke , Christiane Amendt
- Applicant: Merck Patent GmbH
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: Millen White Zelano and Branigan, PC
- Agent John Sopp; Csaba Henter
- Priority: DE102012019369 20121002
- International Application: PCT/EP2013/002696 WO 20130909
- International Announcement: WO2014/053208 WO 20140410
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/4375 ; C07D519/00 ; A61K45/06
Abstract:
The compound 4-(2-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-2,7-naphthyridin-1-ylamine and pharmaceutically usable salts and/or tautomers thereof. The use of this compound for the treatment of tumors, tumor growth, tumor metastases and/or AIDS.
Public/Granted literature
- US20150252041A1 7-AZAINDOLE-2,7-NAPHTHYRIDINE DERIVATIVE FOR THE TREATMENT OF TUMOURS Public/Granted day:2015-09-10
Information query
